• December 17, 2024 – MaaT Pharma - Key Opinion Leader Discussion - ASH 2024
Categorie
Videos
December 18, 2024
On June 7th, 2022, MaaT Pharma hosted its virtual R&D Day to share the latest clinical results of our key…
June 8, 2022
Hervé Affagard, CEO and co-founder of MaaT Pharma, presented the company at the H.C. Wainwright Bioconnect Virtual Conference held January…
January 14, 2022
Webcast, December 13, 2021 Corporate Update: positive results for MaaT013 from Phase 2 clinical trial and early access program Download…
December 17, 2021
Watch the replay of the presentation by Our CEO Herve Affagard, MBA, Eng., during the International Alliance for Biological Standardization…
June 2, 2021
Découvrez ci-dessous l’intervention de notre CEO Herve Affagard, MBA, Eng. pour le Prix de l’Entrepreneur de l’Année de EY. L’équipe d’EY…
May 5, 2021
Our Chief Business Officer Savita Bernal attended HYBRID 2021, on March 16th, an event focused this year on Immunology and Inflammatory…
April 28, 2021
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
Ressources
Contact
Nous sommes une société au stade clinique, spécialisée dans les thérapies issues du microbiote dédiées aux patients atteints de cancer.
Contact
Nous sommes une société au stade clinique, spécialisée dans les thérapies issues du microbiote dédiées aux patients atteints de cancer.